A legal fight over a single amino acid could set retatrutide's exclusivity window, its Medicare negotiation clock, and its competitive future.
|Podcasts|April 25, 2023
Health Equity Conversations: Barriers to Equitable Care
Author(s)Matthew Gavidia
On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion advancing health equity in their respective organization’s policy and practice initiatives.
Advertisement
AJMC.com recently launched a resource center, the
On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion (DEI) advancing health equity in their respective organization’s policy and practice initiatives, including:
- Joneigh Khaldun, MD, MPH, FACEP, vice president and chief health equity officer for CVS Health
- Paul G. Alexander, MD, MPH, executive vice president and chief health equity and transformation officer, RWJBarnabas Health
- Kirk Campbell, MD, FASN, vice chair for DEI in the Department of Medicine at Mount Sinai Health System in New York
Advertisement
Related to this article
A scoping review of 15 studies found psoriasis prevalence markedly lower across 13 indigenous populations worldwide.
The study authors note there is an urgent need for "innovative value-based and alternative payment models of care."
A JAMA analysis of 2021-2023 death records found heat-related mortality varied sharply by occupation and industry among working-age US adults.
Biomarker-driven care is advancing in mantle cell lymphoma, though cost and infrastructure limit access in community oncology, according to a review.
Wet work harms the skin barrier and microbiome as delgocitinib emerges.
Build scalable obesity care with multidisciplinary teams, clear triage, and monitoring protocols; address GLP-1 gaps, Medicare access and price barriers, including oral GLP-1.
CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know if Retatrutide Is Classified as a Biologic
2
Predoc and Nebraska Cancer Specialists: Not Letting the Fax Be the Fumble
3
FDA Approves First Symptomatic Dermographism Treatment
4
Sacral Neuromodulation Still Seen as OAB Gold Standard in Review
5